Alkido Pharma Inc. (NASDAQ: AIKI) Starts Presentation at The LD 500
Alkido Pharma Inc. (NASDAQ: AIKI) is a biotechnology company with a diverse portfolio of small-molecule anti-cancer therapeutics. Aikido's platform consists of patented technology from leading universities and researchers. The company is currently in the process of developing an innovative therapeutic drug platform through strong partnerships with world renowned educational institutions, including The University of Texas at Austin and Wake Forest University. For more information, visit the company's website at www.AIkidoPharma.com About The LD 500 The LD 500 is the most ambitious project in LD Micro's 14-year history of leading the micro-cap space as an independent resource. Investors will enjoy updates…







